UBX - unitybiotechnology.com Profit before payment of interest, taxes and amortization
Unity Biotechnology faces risks due to a lack of revenue and a reliance on equity offerings while developing retinal therapies. Meanwhile, the company's senolytics attract visionaries with the ambition to combat aging. Estimated EBITDA helps assess the current stage of the business relative to its history, where the value captures this metric. Independence from macroeconomic trends and the demand for innovation make the asset a promising defensive tool.
Unity Biotechnology, Inc. (UBX) - metric breakdowns and financial figures
- stock quotes and analyst forecast:
- market capitalization statistics:
- business book valuation details:
- business debt structure and liquidity details:
Aggregate Debt to Capital Unity Biotechnology|UBX - Long-Term Debt to Capital|Current Liabilities to Capital Unity Biotechnology Inc.|UBX - Company Aggregate Debts|Debt to Book Value Unity Biotechnology|UBX - Company Long-Term Debts|Company Short-Term Loans and Borrowings Unity Biotechnology|Immediate Liquidity Ratio unitybiotechnology.com
- company profitability and valuation multiples indicators:
UBX - Company Net Income|Expected Net Profit Unity Biotechnology|UBX - Price to Earnings Ratio|Future Price to Earnings unitybiotechnology.com|UBX - Price/Earnings to Growth Ratio|Company Value to EBITDA Unity Biotechnology|UBX - Operating profit EBITDA|Net earnings per share for the trailing year Unity Biotechnology|UBX - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months unitybiotechnology.com|UBX - Net earnings per share growth this year|Earnings growth forecast for next year Unity Biotechnology
Summary company analytics:UBX - Unity Biotechnology, Inc
This indicator measures daily operating cash flows, providing a real-time assessment of the business's resilience to high borrowing costs. The absolute EBITDA trend is critical for Unity Biotechnology (UBX), as any dips in this metric amid an intense scientific race signal a loss of financial efficiency and the risk of losing support from strategic investors.
Who Unity Biotechnology competes with
Income before deduction of interest, taxes and amortization TEM|Qiagen N.V. - Operating profit EBITDA|IONS: Profit before payment of interest, taxes and amortization|RGEN: Operating profit EBITDA|RNA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization CRISPR Therapeutics Corp|Profit before interest, taxes and amortization GeneDx Corp WGS|Operating profit before deduction of amortization RARE (Ultragenyx Pharmaceutical)|Company profit before taxes, interest and amortization BEAM|Operating profit EBITDA SRPT (Sarepta)|Twist Bioscience Inc (TWST) - Profit before interest, taxes and amortization|10x Genomics Corp - Operating profit EBITDA|Intellia Corp (NTLA) - Operating profit before deduction of amortization|STOK: Operating profit EBITDA|biolifesolutions.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Wave Life Sciences Ltd.|Operating profit before amortization MAZE (Maze Therapeutics, Inc.)|Profit before payment of interest, taxes and amortization Sionna Pharma (SION)|PRME - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Taysha Gene Therapies TSHA|uniqure.com - Profit before payment of interest, taxes and amortization|MGTX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization REGENXBIO Inc|SLDB: Operating profit EBITDA|Operating profit before depreciation charges Ocugen Pharma OCGN|Operating profit before deduction of amortization PACB|Profit before interest, taxes and amortization benitec.com BNTC|Operating profit before deduction of amortization DSGN (Design Therapeutics, Inc.)|Operating profit EBITDA Rocket Pharma (RCKT)|Operating profit EBITDA FDMT (4D Molecular Therapeutics Inc)|Lexeo Therapeutics Inc. - Profit before payment of interest, taxes and amortization|KRRO: Operating profit before deduction of amortization|EDIT (editasmedicine.com) - Operating profit before amortization|SLN: Operating profit EBITDA|Operating profit before amortization PRQR|Profit before payment of interest, taxes and amortization Codexis Inc|Operating profit before amortization SGMO (Sangamo BioSciences)|Operating profit EBITDA NAUT|Operating profit EBITDA metagenomi.co (MGX)|Precision BioSciences, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Generation Bio Co GBIO|BOLD - Profit before payment of interest, taxes and amortization|XCUR (Exicure, Inc.) - Operating profit before amortization|IMNN: Operating profit EBITDA|PHIO - Operating income before deduction of amortization|Operating profit before deduction of amortization MBIO|RNAZ (TransCode) - Company profit before taxes, interest and amortization|Operating profit before deduction of amortization BNGO (Bionano Genomics, Inc.)|APDN - Profit before interest, taxes and amortization|bluebird bio, Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization IPA|Omega Therapeutics, Inc. - Operating profit EBITDA|OMIC: Profit before payment of interest, taxes and amortization|RGLS: Operating profit EBITDA|SYRS - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Telesis Bio, Inc.|Profit before interest, taxes and amortization traconpharma.com TCON
